CombinatoRx plunges on Synavive trial failure - Forbes
|
CombinatoRx plunges on Synavive trial failure
Forbes - AP 10.06.08, 10:04 AM ET The drug candidate Synavive missed its main goal in a clinical trial, developer CombinatoRx Inc. said Monday, as the drug did not significantly improve symptoms of osteoarthritis of the knee compared with a placebo. UPDATE 1-CombinatoRx says drug fails trial, shares slump CombinatoRx Slides In Pre-Market On Disappointing Knee … |
More: continued here
Permalink for CombinatoRx plunges on Synavive trial failure - Forbes